GW HENSSLER & ASSOCIATES LTD
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1080369
KENNESAW, GA
Position in VRTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$10,277,343
+$1,060,758 QoQ
Shares Held
20,690
+0.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#364
of 1,735 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GW HENSSLER & ASSOCIATES LTD holds $25,445,577 across 2 Biotechnology names. VRTX ranks #2 (40.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,326 | $15,168,234 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
20,690 | $10,277,343 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,277,343 | 20,690 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $9,216,585 | 20,640 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,538,582 | 18,834 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,925,867 | 22,791 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $10,134,087 | 22,763 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $11,059,229 | 22,811 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,751,783 | 24,216 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $11,381,902 | 24,473 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||